世界の術後悪心嘔吐（PONV）市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Postoperative Nausea and Vomiting (PONV) Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4710 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、術後悪心嘔吐（PONV）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（セロトニン拮抗薬、ステロイド、ドーパミン拮抗薬、NK-1受容体拮抗薬、非薬理学的治療、その他）、用途別市場規模（病院薬局、オンライン薬局、ドラッグストア）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・術後悪心嘔吐（PONV）の市場動向 ・企業の競争状況、市場シェア ・術後悪心嘔吐（PONV）の種類別市場規模（セロトニン拮抗薬、ステロイド、ドーパミン拮抗薬、NK-1受容体拮抗薬、非薬理学的治療、その他） ・術後悪心嘔吐（PONV）の用途別市場規模（病院薬局、オンライン薬局、ドラッグストア） ・術後悪心嘔吐（PONV）の北米市場規模2016-2027（アメリカ、カナダ） ・術後悪心嘔吐（PONV）のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・術後悪心嘔吐（PONV）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・術後悪心嘔吐（PONV）の中南米市場規模2016-2027（メキシコ、ブラジル） ・術後悪心嘔吐（PONV）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Acacia Pharma、F. Hoffmann-La Roche、Novartis、Ani Pharmaceuticals、Camurus、Sanofi、Helsinn Holding、Eisai、Merck、GlaxoSmithKline） ・結論

The global post-operative nausea and vomiting (PONV) market is growing at a significant rate due to bourgeoning incidence rate of post-operative complications and increasing demand for combination therapy, as well as introduction of promising drugs in this segment across the globe.
Major factors boosting the growth of the post-operative nausea and vomiting market include large number of surgeries performed and rise in the rate of postoperative complications, such as, dizziness, vomiting, and nausea. However, strict regulatory approvals and high health care expenditure are predicted to hamper the growth of the PONV market during the forecast period.

Market Analysis and Insights: Global Postoperative Nausea and Vomiting (PONV) Market
The global Postoperative Nausea and Vomiting (PONV) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Postoperative Nausea and Vomiting (PONV) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Postoperative Nausea and Vomiting (PONV) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Postoperative Nausea and Vomiting (PONV) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Postoperative Nausea and Vomiting (PONV) market.

Global Postoperative Nausea and Vomiting (PONV) Scope and Market Size
Postoperative Nausea and Vomiting (PONV) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Postoperative Nausea and Vomiting (PONV) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Serotonin Antagonists
Steroids
Dopamine Antagonists
NK-1 Receptor Antagonists
Non-pharmacologic Treatment
Others

Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Acacia Pharma
F. Hoffmann-La Roche
Novartis
Ani Pharmaceuticals
Camurus
Sanofi
Helsinn Holding
Eisai
Merck

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Postoperative Nausea and Vomiting (PONV) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Serotonin Antagonists
1.2.3 Steroids
1.2.4 Dopamine Antagonists
1.2.5 NK-1 Receptor Antagonists
1.2.6 Non-pharmacologic Treatment
1.2.7 Others
1.3 Market by Application
1.3.1 Global Postoperative Nausea and Vomiting (PONV) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Postoperative Nausea and Vomiting (PONV) Market Perspective (2016-2027)
2.2 Postoperative Nausea and Vomiting (PONV) Growth Trends by Regions
2.2.1 Postoperative Nausea and Vomiting (PONV) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Postoperative Nausea and Vomiting (PONV) Historic Market Share by Regions (2016-2021)
2.2.3 Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Regions (2022-2027)
2.3 Postoperative Nausea and Vomiting (PONV) Industry Dynamic
2.3.1 Postoperative Nausea and Vomiting (PONV) Market Trends
2.3.2 Postoperative Nausea and Vomiting (PONV) Market Drivers
2.3.3 Postoperative Nausea and Vomiting (PONV) Market Challenges
2.3.4 Postoperative Nausea and Vomiting (PONV) Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Postoperative Nausea and Vomiting (PONV) Players by Revenue
3.1.1 Global Top Postoperative Nausea and Vomiting (PONV) Players by Revenue (2016-2021)
3.1.2 Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Players (2016-2021)
3.2 Global Postoperative Nausea and Vomiting (PONV) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Postoperative Nausea and Vomiting (PONV) Revenue
3.4 Global Postoperative Nausea and Vomiting (PONV) Market Concentration Ratio
3.4.1 Global Postoperative Nausea and Vomiting (PONV) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Postoperative Nausea and Vomiting (PONV) Revenue in 2020
3.5 Postoperative Nausea and Vomiting (PONV) Key Players Head office and Area Served
3.6 Key Players Postoperative Nausea and Vomiting (PONV) Product Solution and Service
3.7 Date of Enter into Postoperative Nausea and Vomiting (PONV) Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Postoperative Nausea and Vomiting (PONV) Breakdown Data by Type
4.1 Global Postoperative Nausea and Vomiting (PONV) Historic Market Size by Type (2016-2021)
4.2 Global Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Type (2022-2027)

5 Postoperative Nausea and Vomiting (PONV) Breakdown Data by Application
5.1 Global Postoperative Nausea and Vomiting (PONV) Historic Market Size by Application (2016-2021)
5.2 Global Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Postoperative Nausea and Vomiting (PONV) Market Size (2016-2027)
6.2 North America Postoperative Nausea and Vomiting (PONV) Market Size by Type
6.2.1 North America Postoperative Nausea and Vomiting (PONV) Market Size by Type (2016-2021)
6.2.2 North America Postoperative Nausea and Vomiting (PONV) Market Size by Type (2022-2027)
6.2.3 North America Postoperative Nausea and Vomiting (PONV) Market Size by Type (2016-2027)
6.3 North America Postoperative Nausea and Vomiting (PONV) Market Size by Application
6.3.1 North America Postoperative Nausea and Vomiting (PONV) Market Size by Application (2016-2021)
6.3.2 North America Postoperative Nausea and Vomiting (PONV) Market Size by Application (2022-2027)
6.3.3 North America Postoperative Nausea and Vomiting (PONV) Market Size by Application (2016-2027)
6.4 North America Postoperative Nausea and Vomiting (PONV) Market Size by Country
6.4.1 North America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2016-2021)
6.4.2 North America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Postoperative Nausea and Vomiting (PONV) Market Size (2016-2027)
7.2 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Type
7.2.1 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Type (2016-2021)
7.2.2 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Type (2022-2027)
7.2.3 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Type (2016-2027)
7.3 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Application
7.3.1 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Application (2016-2021)
7.3.2 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Application (2022-2027)
7.3.3 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Application (2016-2027)
7.4 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Country
7.4.1 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Country (2016-2021)
7.4.2 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size (2016-2027)
8.2 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Type
8.2.1 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Type (2016-2027)
8.3 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Application
8.3.1 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Application (2016-2027)
8.4 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Region
8.4.1 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Postoperative Nausea and Vomiting (PONV) Market Size (2016-2027)
9.2 Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Type
9.2.1 Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Type (2016-2021)
9.2.2 Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Type (2022-2027)
9.2.3 Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Type (2016-2027)
9.3 Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Application
9.3.1 Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Application (2016-2021)
9.3.2 Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Application (2022-2027)
9.3.3 Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Application (2016-2027)
9.4 Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Country
9.4.1 Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2016-2021)
9.4.2 Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size (2016-2027)
10.2 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Type
10.2.1 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Type (2016-2027)
10.3 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Application
10.3.1 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Application (2016-2027)
10.4 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Country
10.4.1 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Acacia Pharma
11.1.1 Acacia Pharma Company Details
11.1.2 Acacia Pharma Business Overview
11.1.3 Acacia Pharma Postoperative Nausea and Vomiting (PONV) Introduction
11.1.4 Acacia Pharma Revenue in Postoperative Nausea and Vomiting (PONV) Business (2016-2021)
11.1.5 Acacia Pharma Recent Development
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Details
11.2.2 F. Hoffmann-La Roche Business Overview
11.2.3 F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Introduction
11.2.4 F. Hoffmann-La Roche Revenue in Postoperative Nausea and Vomiting (PONV) Business (2016-2021)
11.2.5 F. Hoffmann-La Roche Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Postoperative Nausea and Vomiting (PONV) Introduction
11.3.4 Novartis Revenue in Postoperative Nausea and Vomiting (PONV) Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Ani Pharmaceuticals
11.4.1 Ani Pharmaceuticals Company Details
11.4.2 Ani Pharmaceuticals Business Overview
11.4.3 Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Introduction
11.4.4 Ani Pharmaceuticals Revenue in Postoperative Nausea and Vomiting (PONV) Business (2016-2021)
11.4.5 Ani Pharmaceuticals Recent Development
11.5 Camurus
11.5.1 Camurus Company Details
11.5.2 Camurus Business Overview
11.5.3 Camurus Postoperative Nausea and Vomiting (PONV) Introduction
11.5.4 Camurus Revenue in Postoperative Nausea and Vomiting (PONV) Business (2016-2021)
11.5.5 Camurus Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Details
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Postoperative Nausea and Vomiting (PONV) Introduction
11.6.4 Sanofi Revenue in Postoperative Nausea and Vomiting (PONV) Business (2016-2021)
11.6.5 Sanofi Recent Development
11.7 Helsinn Holding
11.7.1 Helsinn Holding Company Details
11.7.2 Helsinn Holding Business Overview
11.7.3 Helsinn Holding Postoperative Nausea and Vomiting (PONV) Introduction
11.7.4 Helsinn Holding Revenue in Postoperative Nausea and Vomiting (PONV) Business (2016-2021)
11.7.5 Helsinn Holding Recent Development
11.8 Eisai
11.8.1 Eisai Company Details
11.8.2 Eisai Business Overview
11.8.3 Eisai Postoperative Nausea and Vomiting (PONV) Introduction
11.8.4 Eisai Revenue in Postoperative Nausea and Vomiting (PONV) Business (2016-2021)
11.8.5 Eisai Recent Development
11.9 Merck
11.9.1 Merck Company Details
11.9.2 Merck Business Overview
11.9.3 Merck Postoperative Nausea and Vomiting (PONV) Introduction
11.9.4 Merck Revenue in Postoperative Nausea and Vomiting (PONV) Business (2016-2021)
11.9.5 Merck Recent Development
11.10 GlaxoSmithKline
11.10.1 GlaxoSmithKline Company Details
11.10.2 GlaxoSmithKline Business Overview
11.10.3 GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Introduction
11.10.4 GlaxoSmithKline Revenue in Postoperative Nausea and Vomiting (PONV) Business (2016-2021)
11.10.5 GlaxoSmithKline Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Postoperative Nausea and Vomiting (PONV) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Serotonin Antagonists
Table 3. Key Players of Steroids
Table 4. Key Players of Dopamine Antagonists
Table 5. Key Players of NK-1 Receptor Antagonists
Table 6. Key Players of Non-pharmacologic Treatment
Table 7. Key Players of Others
Table 8. Global Postoperative Nausea and Vomiting (PONV) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Postoperative Nausea and Vomiting (PONV) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Postoperative Nausea and Vomiting (PONV) Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Postoperative Nausea and Vomiting (PONV) Market Share by Regions (2016-2021)
Table 12. Global Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Postoperative Nausea and Vomiting (PONV) Market Share by Regions (2022-2027)
Table 14. Postoperative Nausea and Vomiting (PONV) Market Trends
Table 15. Postoperative Nausea and Vomiting (PONV) Market Drivers
Table 16. Postoperative Nausea and Vomiting (PONV) Market Challenges
Table 17. Postoperative Nausea and Vomiting (PONV) Market Restraints
Table 18. Global Postoperative Nausea and Vomiting (PONV) Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Postoperative Nausea and Vomiting (PONV) Market Share by Players (2016-2021)
Table 20. Global Top Postoperative Nausea and Vomiting (PONV) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Postoperative Nausea and Vomiting (PONV) as of 2020)
Table 21. Ranking of Global Top Postoperative Nausea and Vomiting (PONV) Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Postoperative Nausea and Vomiting (PONV) Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Postoperative Nausea and Vomiting (PONV) Product Solution and Service
Table 25. Date of Enter into Postoperative Nausea and Vomiting (PONV) Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Postoperative Nausea and Vomiting (PONV) Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Type (2016-2021)
Table 29. Global Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Postoperative Nausea and Vomiting (PONV) Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Application (2016-2021)
Table 33. Global Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Postoperative Nausea and Vomiting (PONV) Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Postoperative Nausea and Vomiting (PONV) Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Postoperative Nausea and Vomiting (PONV) Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Postoperative Nausea and Vomiting (PONV) Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Postoperative Nausea and Vomiting (PONV) Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Postoperative Nausea and Vomiting (PONV) Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Postoperative Nausea and Vomiting (PONV) Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Postoperative Nausea and Vomiting (PONV) Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Postoperative Nausea and Vomiting (PONV) Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Postoperative Nausea and Vomiting (PONV) Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Country (2022-2027) & (US$ Million)
Table 65. Acacia Pharma Company Details
Table 66. Acacia Pharma Business Overview
Table 67. Acacia Pharma Postoperative Nausea and Vomiting (PONV) Product
Table 68. Acacia Pharma Revenue in Postoperative Nausea and Vomiting (PONV) Business (2016-2021) & (US$ Million)
Table 69. Acacia Pharma Recent Development
Table 70. F. Hoffmann-La Roche Company Details
Table 71. F. Hoffmann-La Roche Business Overview
Table 72. F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Product
Table 73. F. Hoffmann-La Roche Revenue in Postoperative Nausea and Vomiting (PONV) Business (2016-2021) & (US$ Million)
Table 74. F. Hoffmann-La Roche Recent Development
Table 75. Novartis Company Details
Table 76. Novartis Business Overview
Table 77. Novartis Postoperative Nausea and Vomiting (PONV) Product
Table 78. Novartis Revenue in Postoperative Nausea and Vomiting (PONV) Business (2016-2021) & (US$ Million)
Table 79. Novartis Recent Development
Table 80. Ani Pharmaceuticals Company Details
Table 81. Ani Pharmaceuticals Business Overview
Table 82. Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Product
Table 83. Ani Pharmaceuticals Revenue in Postoperative Nausea and Vomiting (PONV) Business (2016-2021) & (US$ Million)
Table 84. Ani Pharmaceuticals Recent Development
Table 85. Camurus Company Details
Table 86. Camurus Business Overview
Table 87. Camurus Postoperative Nausea and Vomiting (PONV) Product
Table 88. Camurus Revenue in Postoperative Nausea and Vomiting (PONV) Business (2016-2021) & (US$ Million)
Table 89. Camurus Recent Development
Table 90. Sanofi Company Details
Table 91. Sanofi Business Overview
Table 92. Sanofi Postoperative Nausea and Vomiting (PONV) Product
Table 93. Sanofi Revenue in Postoperative Nausea and Vomiting (PONV) Business (2016-2021) & (US$ Million)
Table 94. Sanofi Recent Development
Table 95. Helsinn Holding Company Details
Table 96. Helsinn Holding Business Overview
Table 97. Helsinn Holding Postoperative Nausea and Vomiting (PONV) Product
Table 98. Helsinn Holding Revenue in Postoperative Nausea and Vomiting (PONV) Business (2016-2021) & (US$ Million)
Table 99. Helsinn Holding Recent Development
Table 100. Eisai Company Details
Table 101. Eisai Business Overview
Table 102. Eisai Revenue in Postoperative Nausea and Vomiting (PONV) Business (2016-2021) & (US$ Million)
Table 103. Eisai Recent Development
Table 104. Merck Company Details
Table 105. Merck Business Overview
Table 106. Merck Postoperative Nausea and Vomiting (PONV) Product
Table 107. Merck Revenue in Postoperative Nausea and Vomiting (PONV) Business (2016-2021) & (US$ Million)
Table 108. Merck Recent Development
Table 109. GlaxoSmithKline Company Details
Table 110. GlaxoSmithKline Business Overview
Table 111. GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Product
Table 112. GlaxoSmithKline Revenue in Postoperative Nausea and Vomiting (PONV) Business (2016-2021) & (US$ Million)
Table 113. GlaxoSmithKline Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Postoperative Nausea and Vomiting (PONV) Market Share by Type: 2020 VS 2027
Figure 2. Serotonin Antagonists Features
Figure 3. Steroids Features
Figure 4. Dopamine Antagonists Features
Figure 5. NK-1 Receptor Antagonists Features
Figure 6. Non-pharmacologic Treatment Features
Figure 7. Others Features
Figure 8. Global Postoperative Nausea and Vomiting (PONV) Market Share by Application: 2020 VS 2027
Figure 9. Hospital Pharmacies Case Studies
Figure 10. Online Pharmacies Case Studies
Figure 11. Retail Pharmacies Case Studies
Figure 12. Postoperative Nausea and Vomiting (PONV) Report Years Considered
Figure 13. Global Postoperative Nausea and Vomiting (PONV) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Postoperative Nausea and Vomiting (PONV) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Postoperative Nausea and Vomiting (PONV) Market Share by Regions: 2020 VS 2027
Figure 16. Global Postoperative Nausea and Vomiting (PONV) Market Share by Regions (2022-2027)
Figure 17. Global Postoperative Nausea and Vomiting (PONV) Market Share by Players in 2020
Figure 18. Global Top Postoperative Nausea and Vomiting (PONV) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Postoperative Nausea and Vomiting (PONV) as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Postoperative Nausea and Vomiting (PONV) Revenue in 2020
Figure 20. Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Type (2016-2021)
Figure 21. Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Type (2022-2027)
Figure 22. North America Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Postoperative Nausea and Vomiting (PONV) Market Share by Type (2016-2027)
Figure 24. North America Postoperative Nausea and Vomiting (PONV) Market Share by Application (2016-2027)
Figure 25. North America Postoperative Nausea and Vomiting (PONV) Market Share by Country (2016-2027)
Figure 26. United States Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Postoperative Nausea and Vomiting (PONV) Market Share by Type (2016-2027)
Figure 30. Europe Postoperative Nausea and Vomiting (PONV) Market Share by Application (2016-2027)
Figure 31. Europe Postoperative Nausea and Vomiting (PONV) Market Share by Country (2016-2027)
Figure 32. Germany Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Share by Region (2016-2027)
Figure 42. China Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Postoperative Nausea and Vomiting (PONV) Market Share by Type (2016-2027)
Figure 50. Latin America Postoperative Nausea and Vomiting (PONV) Market Share by Application (2016-2027)
Figure 51. Latin America Postoperative Nausea and Vomiting (PONV) Market Share by Country (2016-2027)
Figure 52. Mexico Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Share by Country (2016-2027)
Figure 58. Turkey Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Acacia Pharma Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2016-2021)
Figure 62. F. Hoffmann-La Roche Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2016-2021)
Figure 63. Novartis Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2016-2021)
Figure 64. Ani Pharmaceuticals Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2016-2021)
Figure 65. Camurus Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2016-2021)
Figure 66. Sanofi Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2016-2021)
Figure 67. Helsinn Holding Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2016-2021)
Figure 68. Eisai Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2016-2021)
Figure 69. Merck Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2016-2021)
Figure 70. GlaxoSmithKline Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

---